Search

everythinglearnresearchcommunity

for

Search:↓

Immune checkpoint inhibitors can increase the risk of autoimmune skin diseases, especially bullous pemphigoid.

Connexin-26 gene mutations may increase cancer risk in KID syndrome patients.

CPK1 helps root hair growth in Arabidopsis by activating channels for calcium signaling.

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.

Y27632 increases cell growth through EGFR signaling, not ROCK1/2.

Entospletinib effectively prevents eye and skin GVHD in mice.

EGFR and MEK inhibitors reduce PD-L1 in hair follicles, possibly causing inflammation.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

Upadacitinib is effective and safe for treating severe alopecia areata in teens.

Doxil showed some effectiveness against advanced prostate cancer but caused severe side effects at higher doses.

Combining irinotecan and cetuximab is effective for some metastatic colorectal cancer patients but often causes manageable skin issues.

The new chemotherapy combination for advanced lung cancer showed a 35.7% response rate but caused significant side effects.

Vemurafenib therapy can cause hair loss, but clobetasol propionate foam can help regrow hair.

TB and BCC tumors show similar follicular differentiation patterns.

Keratinocyte cytokines and genetic variations influence the development of moles and skin pigmentation.

Activating certain cells in hair follicles can prevent hair loss caused by cancer treatments.

Ritlecitinib effectively reduces hair loss in JAK inhibitor-naïve alopecia areata patients.

Researchers discovered potential origins and new treatments for skin cancer, including biomarkers for melanoma and therapies that reduce tumor growth.

New drugs targeting the JAK-STAT pathway show promise for treating inflammatory skin diseases.

SKH1 hairless mice have identifiable epidermal stem cells with specific markers.

Topical JAK inhibitors may help children with alopecia areata regrow hair.

PRMT5 inhibitors effectively fight adenoid cystic carcinoma in salivary glands.

Increasing ABC transporters in hair follicles may prevent chemotherapy-induced hair loss.

A PIK3CA mutation in Schwann cells causes severe nerve damage and increased glycolysis, but early treatment can help.

A chemical called 5-Bromo-2′-deoxyuridine caused rapid hair loss in mice by killing certain skin cells through a specific cell death pathway.

Brepocitinib improves cicatricial alopecia and reduces key immune markers.

The anti-CXCL4 antibody helps mice grow hair faster and prevents hair loss.

Chemotherapy adds to, but doesn't enhance, the effects of immunotherapy in lung cancer treatment.